Merck completed the acquisition of Chromatography Business of JSR Life Sciences.

Merck, a pharmaceutical and chemical company, completed the acquisition of the Chromatography Business of JSR Life Sciences, a provider of research & bioprocess services. Financial terms were not disclosed. "This acquisition positions our innovative Amsphere Protein A technologies for even greater global impact under Merck's renowned platform—enabling more customers worldwide to accelerate therapies to market with enhanced speed and confidence,” Tim Lowery, JSR Life Sciences President.